For the quarter ending 2026-03-31, SBFMW had -$2,176,618 decrease in cash & cash equivalents over the period. -$2,077,229 in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents at beginning of period | - | - | 9,686,529 | - |
| Net (loss) | -1,243,869 | -2,140,927 | -883,820 | -2,950,605 |
| Disposal of tangible assets | - | 7 | 10,250 | - |
| Stock issued for services | - | 0 | 0 | 0 |
| Intangible assets impairment | - | 131,788 | 554,650 | 1,061,809 |
| Depreciation and amortization | 76,859 | 98,581 | 96,163 | 137,326 |
| Accounts receivable | 609,601 | -41,293 | 649,850 | -492,384 |
| Inventory | -78,399 | -772,796 | 1,286,164 | 1,123,909 |
| Deposits | 71,740 | - | - | - |
| Prepaid expenses | -154,726 | -189,082 | -36,168 | -255,548 |
| Reduction in right-of-use asset | - | - | -147,016 | - |
| Right-of-use asset | - | -109,434 | - | -94,402 |
| Reduction in right-of-use asset | 52,788 | - | - | - |
| Accounts payable & accrued expenses | -455,836 | -565,040 | 1,224,786 | -849,702 |
| Lease liability | -54,001 | -57,782 | -129,741 | - |
| Earn-out payable | - | 0 | 0 | 0 |
| Income tax payable | 175 | -152,874 | 162,992 | -10,118 |
| Net cash flows (used in) operating activities | -2,072,100 | -1,616,006 | -727,800 | -2,987,267 |
| Purchase of intangible assets | 99,389 | 40,998 | 26,103 | 594,714 |
| Purchase of equipment | 5,129 | -1,039 | 8,040 | 167,490 |
| Net cash flows (used in) investing activities | -104,518 | -50,209 | -118,295 | -667,802 |
| Proceeds from public offering net (common stock) | - | 0 | 0 | 1,828,596 |
| Exercise of warrants | 0 | 724,500 | 0 | 2,195,312 |
| Purchase of treasury stock | - | 0 | 0 | 0 |
| Lease liability | - | - | - | 75,536 |
| Net cash flows provided by financing activities | 0 | 724,500 | 75,536 | 3,948,372 |
| Net increase (decrease) in cash and cash equivalents | -2,176,618 | -941,715 | -770,560 | 293,304 |
| Effect of exchange rate changes on cash | - | - | 97,165 | - |
| Cash and cash equivalents at end of period | - | - | 9,306,438 | - |
Sunshine Biopharma Inc. (SBFMW)
Sunshine Biopharma Inc. (SBFMW)